PE-backed Emmes buys Neox

The Emmes Company, which is backed by Behrman Capital, has acquired Prague-based Neox, a clinical research focused on human health and biopharmaceutical innovation.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this